Steven Cohen's MIRM Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 346,991 shares of Mirum Pharmaceuticals, Inc. (MIRM) worth $32.06 M, representing 0.04% of the portfolio. First purchased in 2020-Q2, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in MIRM, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 531,809 shares. Largest reduction occurred in Q3 2023, reducing 601,038 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Mirum Pharmaceuticals (MIRM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Mirum Pharmaceuticals (MIRM) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +156,353 | Add 82.02% | 346,991 | $92.38 |
| Q4 2025 | -600,037 | Reduce 75.89% | 190,638 | $78.99 |
| Q3 2025 | +531,809 | Add 205.44% | 790,675 | $73.31 |
| Q2 2025 | +26,768 | Add 11.53% | 258,866 | $50.89 |
| Q1 2025 | +232,098 | New Buy | 232,098 | $45.05 |
| Q3 2023 | -601,038 | Sold Out | 0 | $0.00 |
| Q2 2023 | +43,600 | Add 7.82% | 601,038 | $25.87 |
| Q1 2023 | +217,928 | Add 64.19% | 557,438 | $24.02 |
| Q4 2022 | +339,510 | New Buy | 339,510 | $19.50 |
| Q2 2022 | -153,389 | Sold Out | 0 | $0.00 |
| Q1 2022 | -161,454 | Reduce 51.28% | 153,389 | $22.02 |
| Q4 2021 | +170,443 | Add 118.04% | 314,843 | $15.95 |
| Q3 2021 | +125,600 | Add 668.09% | 144,400 | $19.92 |
| Q2 2021 | +13,800 | Add 276.00% | 18,800 | $17.29 |
| Q1 2021 | +5,000 | New Buy | 5,000 | $19.80 |
| Q3 2020 | -97,415 | Sold Out | 0 | $0.00 |
| Q2 2020 | +97,415 | New Buy | 97,415 | $19.46 |
Steven Cohen's Mirum Pharmaceuticals Investment FAQs
Steven Cohen first purchased Mirum Pharmaceuticals, Inc. (MIRM) in Q2 2020, acquiring 97,415 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Mirum Pharmaceuticals, Inc. (MIRM) for 17 quarters since Q2 2020.
Steven Cohen's largest addition to Mirum Pharmaceuticals, Inc. (MIRM) was in Q3 2025, adding 790,675 shares worth $57.96 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 346,991 shares of Mirum Pharmaceuticals, Inc. (MIRM), valued at approximately $32.06 M.
As of the Q1 2026 filing, Mirum Pharmaceuticals, Inc. (MIRM) represents approximately 0.04% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Mirum Pharmaceuticals, Inc. (MIRM) was 790,675 shares, as reported at the end of Q3 2025.